Safety and efficacy of catheter ablation of atrial fibrillation in the very elderly (≥80 years old): Insights from the UC San Diego AF Ablation Registry

被引:5
|
作者
Aldaas, Omar [1 ]
Darden, Douglas [1 ]
Mylavarapu, Praneet [1 ]
Aldaas, Amer [2 ]
Han, Frederick [1 ]
Hoffmayer, Kurt [1 ]
Krummen, David [1 ]
Ho, Gordon [1 ]
Raissi, Farshad [1 ]
Feld, Gregory [1 ]
Hsu, Jonathan [1 ,3 ]
机构
[1] Univ Calif San Diego Hlth Syst, Div Cardiac Electrophysiol, La Jolla, CA USA
[2] AT Still Univ, Sch Osteopath Med, Mesa, AZ USA
[3] Univ Calif San Diego, Dept Med, Div Cardiol, Cardiac Electrophysiol Sect, 9452 Med Ctr Dr,3rd Floor,Room 3E-417, La Jolla, CA 92037 USA
关键词
atrial fibrillation; catheter ablation; complications; hospitalizations; mortality; very elderly; TERM CLINICAL-EFFICACY; RISK; ANTICOAGULATION; PREVALENCE; MANAGEMENT; STROKE;
D O I
10.1002/clc.24137
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundCatheter ablation improves outcomes in symptomatic atrial fibrillation (AF) patients. However, its safety and efficacy in the very elderly (>= 80 years old) is not well described.HypothesisAblation of AF in the very elderly is safe and effective.MethodsWe performed a retrospective study of all patients who underwent catheter ablation enrolled in the University of California, San Diego AF Ablation Registry. The primary outcome was freedom from atrial arrhythmias on or off antiarrhythmic drugs (AADs).ResultsOf 847 patients, 42 (5.0%) were 80 years of age or greater with a median age of 81.5 (80-82.3) and 805 (95.0%) were less than 80 years of age with a median age of 64.4 (57.6-70.2). Among those who were >= 80 years old, 29 were undergoing de novo ablation (69.0%), whereas in the younger cohort, 518 (64.5%) were undergoing de novo ablation (p = .548). There were no statistically significant differences in fluoroscopy (p = .406) or total procedure times (p = .076), AAD use (p = .611), or procedural complications (p = .500) between groups. After multivariable adjustment, there were no statistically significant differences in recurrence of any atrial arrhythmias on or off AAD (adjusted hazard ratio [AHR]: 0.75; 95% confidence interval [CI]: 0.45-1.23; p = .252), all-cause hospitalizations (AHR: 0.86; 95% CI: 0.46-1.60; p = .626), or all-cause mortality (AHR: 4.48; 95% CI: 0.59-34.07; p = .147) between the very elderly and the younger cohort.ConclusionIn this registry analysis, catheter ablation of AF appears similarly effective and safe in patients 80 years or older when compared to a younger cohort. Kaplan-Meier plots of long-term recurrence of atrial arrhythmias on or off antiarrhythmic drugs (excluding a 3-month postprocedural blanking period), long-term rate of all-cause hospitalizations, and long-term rate of all-cause mortality. Patients who were 80 years of age or older and a younger cohort are compared.image
引用
收藏
页码:1488 / 1494
页数:7
相关论文
共 50 条
  • [41] Impact of sinus rhythm maintenance on major adverse cardiac and cerebrovascular events after catheter ablation of atrial fibrillation: insights from AF frontier ablation registry
    Keisuke Usuda
    Takeshi Kato
    Toyonobu Tsuda
    Hayato Tada
    Satoru Niwa
    Soichiro Usui
    Kenji Sakata
    Kenshi Hayashi
    Hiroshi Furusho
    Masaaki Kawashiri
    Masayuki Takamura
    Takayuki Otsuka
    Shinya Suzuki
    Akio Hirata
    Masato Murakami
    Mitsuru Takami
    Masaomi Kimura
    Hidehira Fukaya
    Shiro Nakahara
    Wataru Shimizu
    Yu-ki Iwasaki
    Hiroshi Hayashi
    Tomoo Harada
    Ikutaro Nakajima
    Ken Okumura
    Junjiroh Koyama
    Michifumi Tokuda
    Teiichi Yamane
    Yukihiko Momiyama
    Kojiro Tanimoto
    Kyoko Soejima
    Noriko Nonoguchi
    Koichiro Ejima
    Nobuhisa Hagiwara
    Masahide Harada
    Kazumasa Sonoda
    Masaru Inoue
    Koji Kumagai
    Hidemori Hayashi
    Kazuhiro Satomi
    Yoshinao Yazaki
    Yuji Watari
    Masaru Arai
    Ryuta Watanabe
    Katsuaki Yokoyama
    Naoya Matsumoto
    Koichi Nagashima
    Yasuo Okumura
    Heart and Vessels, 2022, 37 : 327 - 336
  • [42] Type natriuretic peptide predicts major adverse cardiac and cerebrovascular events after catheter ablation of atrial fibrillation: insights from AF frontier ablation registry
    Kato, T.
    Usuda, K.
    Tada, H.
    Tsuda, T.
    Takeuchi, K.
    Niwa, S.
    Hayashi, K.
    Furusho, H.
    Takamura, M.
    Nagashima, K.
    Okumura, Y.
    EUROPEAN HEART JOURNAL, 2020, 41 : 604 - 604
  • [43] Safety and efficacy of circumferential pulmonary vein catheter ablation of atrial fibrillation
    Vasamreddy, CR
    Dalal, D
    Eldadah, Z
    Dickfeld, T
    Jayam, VK
    Henrickson, C
    Meininger, G
    Dong, J
    Lickfett, L
    Berger, R
    Calkins, H
    HEART RHYTHM, 2005, 2 (01) : 42 - 48
  • [44] Catheter Ablation for Paroxysmal Atrial Fibrillation With Sick Sinus Syndrome Insights From the Kansai Plus Atrial Fibrillation Registry
    Morishima, Itsuro
    Kanzaki, Yasunori
    Morita, Yasuhiro
    Inoue, Koichi
    Kobori, Atsushi
    Kaitani, Kazuaki
    Kurotobi, Toshiya
    Yamaji, Hirosuke
    Matsui, Yumie
    Nakazawa, Yuko
    Kusano, Kengo
    Tomomatsu, Toshiro
    Ikai, Yoshihiro
    Furui, Koichi
    Yamauchi, Ryota
    Miyazawa, Hiroyuki
    Tanaka, Nobuaki
    Morimoto, Takeshi
    Kimura, Takeshi
    Shizuta, Satoshi
    PAF Registry investigat
    HEART LUNG AND CIRCULATION, 2023, 32 (02): : 205 - 214
  • [45] Efficacy and safety of catheter ablation for atrial fibrillation in patients with history of cancer
    Ganatra, Sarju
    Abraham, Sonu
    Kumar, Ashish
    Parikh, Rohan
    Patel, Rushin
    Khadke, Sumanth
    Kumar, Amudha
    Liu, Victor
    Diaz, Andrea Nathalie Rosas
    Neilan, Tomas G.
    Martin, David
    Hook, Bruce
    Dani, Sourbha S.
    Asnani, Aarti
    Nohria, Anju
    CARDIO-ONCOLOGY, 2023, 9 (01)
  • [46] Efficacy and safety of catheter ablation for atrial fibrillation in patients with history of cancer
    Sarju Ganatra
    Sonu Abraham
    Ashish Kumar
    Rohan Parikh
    Rushin Patel
    Sumanth Khadke
    Amudha Kumar
    Victor Liu
    Andrea Nathalie Rosas Diaz
    Tomas G. Neilan
    David Martin
    Bruce Hook
    Sourbha S. Dani
    Aarti Asnani
    Anju Nohria
    Cardio-Oncology, 9
  • [47] A worldwide survey on the methods, efficacy, and safety of catheter ablation of atrial fibrillation
    Cappato, R
    Calkins, H
    Chen, SA
    Davies, W
    Iesaka, Y
    Ibaraki, T
    Kalman, J
    Kim, YH
    Klein, G
    Packer, D
    Skanes, A
    CIRCULATION, 2004, 110 (17) : 541 - 542
  • [48] Updated National Multicenter Registry on Procedural Safety of Catheter Ablation for Atrial Fibrillation
    Bertaglia, Emanuele
    Stabile, Giuseppe
    Pappone, Alessia
    Themistoclakis, Sakis
    Tondo, Claudio
    De Sanctis, Valerio
    Soldati, Ezio
    Tritto, Massimo
    Solimene, Francesco
    Grimaldi, Massimo
    Zoppo, Franco
    Pandozi, Claudio
    Augello, Giuseppe
    Calo, Leonardo
    Pappone, Carlo
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2013, 24 (10) : 1069 - 1074
  • [49] Cryoballoon versus radiofrequency ablation for atrial fibrillation - a study of outcome and safety based on the ESC-EHRA AF ablation long-term registry and the Swedish catheter ablation registry
    Mortsell, D.
    Arbelo, E.
    Dagres, N.
    Brugada, J.
    Trines, S.
    Malmborg, H.
    Hoglund, N.
    Tavazzi, L.
    Stabile, G.
    Blomstrom Lundqvist, C.
    EUROPEAN HEART JOURNAL, 2018, 39 : 52 - 52
  • [50] Catheter Ablation for Atrial Fibrillation in the Real World - Insights From the J-CARAF Registry
    Kumar, Saurabh
    Kalman, Jonathan M.
    CIRCULATION JOURNAL, 2014, 78 (05) : 1055 - 1057